亚太地区抗体发现市场预测至 2030 年 - 区域分析 - 按抗体类型(单克隆抗体、多克隆抗体及其他)、性质(人类和人源化、嵌合和鼠类)、服务(噬菌体展示、杂交瘤、转基因动物、单细胞和酵母展示)和最终用户(制药和生物技术公司、研究实验室及其他)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 90    |    Report Code: BMIRE00030716    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Antibody Discovery Market
2022 年亚太地区抗体发现市场价值为 6589.6505 亿美元,预计到 2030 年将达到 11586.8186 亿美元;预计 2022 年至 2030 年的复合年增长率为 7.3%。

发展中地区生物技术产业的扩散推动了亚太地区抗体发现市场的发展

抗体在识别抗原方面的出色精确度使其成为科学家和临床医生的宝贵工具。在现代生物技术中,从基础研究到创新医学评估,许多过程都需要抗体。治疗性抗体的发展为治疗各种疾病开辟了新途径,展示了这些粒子的转化能力。抗体在基于抗体的诊断中也至关重要,因为它们为疾病识别提供了准确可靠的方法。政府的支持不断增加、公私伙伴关系不断增加、疾病状况不断变化以及资金活动不断增加,正在广泛提高亚太等地区生物技术产业的表现。

根据经济合作与发展组织 (OECD) 的数据,截至 2019 年,中国在研发支出方面处于领先地位。大量投资鼓励医疗保健领域采用先进技术。亚洲等地区的国家政府提供税收优惠、更便宜的土地和直接投资,以鼓励生物技术公司扩大产能和增强能力。因此,台湾、马来西亚、印度、中国、新加坡和日本等国家是生物技术产业最有利的目的地。此外,这些亚洲国家更专注于将基因组学、蛋白质组学和生物标志物进步用于诊断和治疗应用。因此,发展中地区生物技术产业的持续发展预计将在未来几年为抗体发现市场创造机会。

亚太抗体发现市场概览

亚太抗体发现市场分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。中国在 2022 年占据了最大的市场份额,预计印度在预测期内将在市场上实现显着的复合年增长率。中国的生物制药行业正在经历巨大的转变,从以仿制药为中心的格局发展为蓬勃发展的创新中心。此外,工业化的进步以及新药、高端医疗设备和技术的应用促进了中国抗体发现市场的增长。

中国正在经历心血管疾病和其他慢性疾病患病率的激增。根据《生物医学与环境科学杂志》的报道,2021 年该国有近 3.3 亿人患有心血管疾病。抗体产品对于开发针对心血管疾病的新型疗法至关重要。因此,心脏病的流行率不断上升引发了对抗体发现的需求。借助研究中心,可以研究抗体序列,开发新的抗体,并优化现有的抗体。根据 Scimago 研究所排名,截至 2022 年,中国拥有近 170 个医学研究中心,其次是日本(72 个)、澳大利亚(53 个)和印度(17 个)。此外,越来越多的市场参与者将重点放在亚太地区的国家,以实现其地理扩张和其他增长战略,研究中心数量的增加以及政府资金的显着增加,推动了亚太地区抗体发现市场的增长。

亚太抗体发现市场收入和预测到 2030 年(十亿美元)

亚太抗体发现市场细分

亚太抗体发现市场分为抗体类型、性质、服务、最终用户和国家。

根据抗体类型,亚太抗体发现市场分为单克隆抗体、多克隆抗体和其他。单克隆抗体细分市场在 2022 年占据了亚太地区抗体发现市场的最大份额。

就性质而言,亚太地区抗体发现市场细分为人类和人源化、嵌合和鼠类。人类和人源化细分市场在 2022 年占据了亚太地区抗体发现市场的最大份额。

按服务划分,亚太地区抗体发现市场分为噬菌体展示、杂交瘤、转基因动物、单细胞和酵母展示。噬菌体展示细分市场在 2022 年占据了亚太地区抗体发现市场的最大份额。

根据最终用户,亚太地区抗体发现市场分为制药和生物技术公司、研究实验室和其他。制药和生物技术公司细分市场在 2022 年占据了亚太地区抗体发现市场的最大份额。

根据国家/地区,亚太地区抗体发现市场分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。 2022 年,中国占据了亚太抗体发现市场的主导份额。

Charles River Laboratories International Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp 和 Biocytogen Pharmaceuticals Beijing Co Ltd. 是亚太抗体发现市场的一些领先公司。

Asia Pacific Antibody Discovery Strategic Insights

Strategic insights for Asia Pacific Antibody Discovery involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-antibody-discovery-market-strategic-framework.webp
Get more information on this report

Asia Pacific Antibody Discovery Report Scope

Report Attribute Details
Market size in 2022 US$ 6,58,965.05 Million
Market Size by 2030 US$ 11,58,681.86 Million
Global CAGR (2022 - 2030) 7.3%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 抗体类型
  • 单克隆抗体
  • 多克隆抗体
By 自然
  • 人类和人源化
  • 嵌合
  • é¼ ç±»
By 最终用户
  • 制药和生物技术公司
  • 研究实验室
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Charles River Laboratories International Inc
  • BioDuro LLC
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • Biocytogen Pharmaceuticals Beijing Co Ltd
  • Get more information on this report

    Asia Pacific Antibody Discovery Regional Insights

    The regional scope of Asia Pacific Antibody Discovery refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-antibody-discovery-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Antibody Discovery Market

    1. Charles River Laboratories International Inc
    2. BioDuro LLC
    3. Sartorius AG
    4. Aragen Life Sciences Ltd
    5. Twist Bioscience Corp
    6. Biocytogen Pharmaceuticals Beijing Co Ltd
    Frequently Asked Questions
    How big is the Asia Pacific Antibody Discovery Market?

    The Asia Pacific Antibody Discovery Market is valued at US$ 6,58,965.05 Million in 2022, it is projected to reach US$ 11,58,681.86 Million by 2030.

    What is the CAGR for Asia Pacific Antibody Discovery Market by (2022 - 2030)?

    As per our report Asia Pacific Antibody Discovery Market, the market size is valued at US$ 6,58,965.05 Million in 2022, projecting it to reach US$ 11,58,681.86 Million by 2030. This translates to a CAGR of approximately 7.3% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Antibody Discovery Market report typically cover these key segments-

  • 抗体类型 (单克隆抗体, 多克隆抗体)
  • 自然 (人类和人源化, 嵌合, 鼠类)
  • 最终用户 (制药和生物技术公司, 研究实验室)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Antibody Discovery Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Antibody Discovery Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Antibody Discovery Market?

    The Asia Pacific Antibody Discovery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Charles River Laboratories International Inc
  • BioDuro LLC
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • Biocytogen Pharmaceuticals Beijing Co Ltd
  • Who should buy this report?

    The Asia Pacific Antibody Discovery Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Antibody Discovery Market value chain can benefit from the information contained in a comprehensive market report.